Chang SP, et al. - In this meta-analysis, researchers investigated the clinical efficacy and safety of nemonoxacin in comparison with levofloxacin in treating community-acquired pneumonia (CAP). They included 3 randomized controlled trials (RCTs) that evaluated nemonoxacin and levofloxacin in the treatment of CAP, on searching the Pubmed, Embase, ClinicalTrials.gov., and the Cochrane databases up to September 2018. Analysis revealed comparable clinical and microbiologic efficacy of nemonoxacin to that of levofloxacin in the treatment of CAP. Furthermore, this agent was as well tolerated as levofloxacin.